Vicki Kelemen, Executive VP and COO at Cardiff Oncology, Inc. (CRDF), bought 960 shares at $10.31 ($10K) on 2021-03-23, disclosed to the SEC on 2021-03-23.
Open-market purchase of $10k CRDF by Executive VP and COO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Several strong factors at once. The rarest rating we give.